Abstract:BackgroundThere is compelling evidence associating senescent cells with the malignant progression of tumours. Of all senescence-related mechanisms, the so-called senescence-associated secretory phenotype (SASP) has attracted much attention. Since the pro-inflammatory cytokines IL-6 and IL-8 are consistently present in the SASP, and secreted by highly aggressive breast cancer cell lines, we aimed at elucidating their role on the less aggressive breast cancer cell line MCF-7, which does not secret these cytokines.MethodsThe MCF-7 cell line was treated with either senescence-conditioned medium (SCM), IL-6 or IL-8 and then evaluated for phenotypic (CD44 and CD24 by FACS) and functional changes associated with an EMT program (migration/invasion) and for the acquisition of stem cell properties: mammosphere-forming capacity, expression of reprogramming factors (by qRT-PCR) and multilineage differentiation potential. We also evaluated the role of IL6 and IL8 in the cytokine-secreting, highly tumorigenic cell line MDA-MB-231.ResultsOur results show that treatment of MCF-7 cells with IL6 and IL8, alone or together, induced the appearance of cells with fibroblastoid morphology, increased CD44 expression and migration, self-renewal and multilineage differentiation capacity, all characteristics compatible with an EMT program and stemness. These changes closely resembled those induced by a SCM. Interestingly, SCM treatments further increased IL6 and IL8 secretion by MCF-7 cells, thus suggesting the participation of an autocrine loop. Indeed, neutralizing antibodies against IL6 and IL8 reversed the effects of SCM on MCF-7, pinpointing these cytokines as major mediators of EMT and stemness-related effects associated with the senescent microenvironment. Additionally, prolonged exposure of MCF cells to IL6 or IL8 induced the appearance of senescent cells, suggesting a mechanism by which senescence and inflammation are reinforced favouring the acquisition of EMT and stem-like features at the population level, thus increasing tumour aggressiveness. Strikingly, our results also show that both IL6 and IL8 are important to maintain aggressive traits in MDA-MB-231 cells, a highly tumorigenic cell line, which appears to be devoid of stemness-related features.ConclusionsThis study demonstrates that, similar to what is observed with a senescent microenvironment, purified IL6 and IL8 induce a self- and cross-reinforced senescence/inflammatory milieu responsible for the emergence of epithelial plasticity and stemness features, thus conferring more aggressive phenotypes to a luminal breast cancer cell line. On the other hand, the basal-like MDA-MB-231 cells, whose aggressiveness-related features depend on IL6 and IL8 secretion, almost completely lack mammosphere formation and differentiation capacities, suggesting that tumour aggressiveness is not always related to stemness.

Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Human Intrahepatic Biliary Epithelial Cells

Interleukin-6 and pro inflammatory status in the breast tumor microenvironment

IL-6 and TNF-α Promote Metastasis of Lung Cancer by Inducing Epithelial-Mesenchymal Transition

Interleukin-6 Promotes Cervical Cancer Development Through Janus Kinase 2/signal Transducer and Activator of Transcription 6 Signaling Pathway

IL-13/STAT6 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Colorectal Cancer Cells.

Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition Via Downregulation of Mir-200 Family in Breast Cancer Cells

Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition

Integrin-linked Kinase Overexpression Promotes Epithelial-Mesenchymal Transition Via Nuclear Factor-Κb Signaling in Colorectal Cancer Cells.

Interleukin-6–mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors

2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition Via the Inhibition of JAK2/STAT3 Signaling Pathway in MCF-7 Cells

[Effects of Interleukin-6 in Epithelial-Mesenchymal Transition of Barrett's Esophagus Cells].

IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells Via Regulation of Hippo Pathways

The Effects and Mechanism of IL-6 on the Epithelial to Mesenchymal Transition of Pancreatic Cancer Cells

Expression of Interleukin-6 is Associated with Epithelial-Mesenchymal Transition and Survival Rates in Gallbladder Cancer.

IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway

Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

Abstract 3425: Interleukin-27 Inhibits Epithelial Mesenchymal Transition in Lung Carcinogenesis

Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42

Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6/STAT3/TGM2 axis